Skip to main content

Oral evidence transcripts

Science, Innovation and Technology Committee

Committee documents that were published online before May 2010 are available by session on the Pre-2010 Publications page.

Total results 353 (page 16 of 18)
28 April 2014
Inquiry Blood, tissue and organ screening
Witnesses Dr Richard Baker, Executive Committee Member, British Transplantation Society, Dr Mike Knapton, Associate Medical Director (Prevention & Care), British Heart Foundation, Ed Owen, Chief Executive, Cystic Fibrosis Trust, and Keith Rigg, Chair, Transplant 2013
Oral Evidence
23 June 2014
Inquiry Social media data and real time analytics
Witnesses Professor Derek McAuley, Professor of Digital Economy in the School of Computer Science and Director of Horizon, Horizon Digital Economy Research Institute, Professor David De Roure, Director, Oxford e-Research Institute and ESRC Strategic Adviser for Data Resources, Economic and Social Research Council, and Sir Nigel Shadbolt, Professor of Artificial Intelligence, Web Science Trust; Professor Liesbet van Zoonen, Professor of Communication and Media Studies, Loughborough University, Professor David Robertson, Head of School of Informatics, University of Edinburgh, representing the UK Computing Research Committee, Dr Mathieu d’Aquin, Research Fellow, the Open University, and Emma Carr, Acting Director, Big Brother Watch
Oral Evidence
18 June 2014
Inquiry Social media data and real time analytics
Witnesses Timo Hannay, Managing Director, Digital Science, Carl Miller, Research Director, Centre for the Analysis of Social Media, Demos, Sureyya Cansoy, Director, Tech for Business and Consumer Programmes, techUK; Professor John Preston, Professor of Education, University of East London Professor Mick Yates, Visiting Professor, Consumer Data Research Centre, University of Leeds Dr Ella McPherson, Research Fellow, University of Cambridge
Oral Evidence
30 April 2014
Inquiry Blood, tissue and organ screening
Witnesses Professor James Neuberger, Associate Medical Director, NHS Blood and Transplant, Dr Lorna Williamson, Medical and Research Director, NHS Blood and Transplant, Dr Paul Cosford, Director for Health Protection and Medical Director, Public Health England, and Dr Katy Sinka, Consultant Epidemiologist and Head of CJD Section, Public Health England; Jane Ellison MP, Parliamentary Under-Secretary of State for Public Health, Department of Health, and Professor Dame Sally Davies, Chief Medical Officer, Department of Health
Oral Evidence
5 February 2014
Inquiry Blood, tissue and organ screening
Witnesses Mark Ward and Joseph Peaty, Secretary and Head of Publicity, TaintedBlood, Liz Carroll, Chief Executive, Haemophilia Society, Dr Matthew Buckland, Chair, Medical Advisory Panel, UK Primary Immunodeficiency Network, and Consultant Immunologist, Barts Health NHS Trust, and Christine Lord; Professor Marc Turner, Chair, Advisory Committee on the Safety of Blood, Tissues and Organs Prion Group, and Chair, UK Blood Services Prion Working Group, Dr Roland Salmon, Acting Chair, Advisory Committee on Dangerous Pathogens, and Dr Sheila MacLennan, Professional Director, UK Blood Services Joint Professional Advisory Committee
Oral Evidence
7 May 2014
Inquiry National Health Screening
Witnesses Professor Jane Wardle, Professor of Clinical Psychology and Director of the Health Behaviour Research Centre at University College London, representing the Academy of Medical Sciences, Jessica Kirby, Senior Health Information Manager, Cancer Research UK, and Dr Sian Taylor-Phillips, Senior Research Fellow, Warwick Medical School, University of Warwick
Oral Evidence
2 April 2014
Inquiry GO-Science Review of Science Advisory Councils 2013
Witnesses Professor Sir Mark Walport, Chief Scientific Adviser to HM Government and Head of the Government Office for Science, Professor Chris Gilligan, Chair, Science Advisory Council, Department for Environment, Food and Rural Affairs, and Professor Les Iversen, Chair, Advisory Council on the Misuse of Drugs, Home Office
Oral Evidence
26 March 2014
Inquiry Blood, tissue and organ screening
Witnesses Professor Richard Knight, Director, National CJD Research and Surveillance Unit, Professor Sheila Bird, Programme Leader, Medical Research Council Biostatistics Unit, Dr Paula Bolton-Maggs, Medical Director, Serious Hazards of Transfusion (SHOT) Haemovigilance Scheme, Dr Simon Mead, Association of British Neurologists
Oral Evidence
12 March 2014
Inquiry Antimicrobial resistance (AMR)
Witnesses Professor Dame Sally Davies, Chief Medical Officer, Department of Health, Sally Wellsteed, Antimicrobial Resistance and Healthcare Associated Infections Team Leader, Department of Health, and Nigel Gibbens, Chief Veterinary Officer, Department for Environment, Food and Rural Affairs; George Eustice MP, Parliamentary Under Secretary of State for Farming, Food and Marine Environment, Department for Environment, Food and Rural Affairs, Jane Ellison MP, Parliamentary Under Secretary of State for Public Health, Department of Health, Professor Dame Sally Davies, Chief Medical Officer, Department of Health, and Professor Peter Borriello, Chief Executive, Veterinary Medicines Directorate
Oral Evidence
26 February 2014
Inquiry Antimicrobial resistance (AMR)
Witnesses Professor Jeremy Farrar, Director, Wellcome Trust, Professor Sir John Savill, Chief Executive Officer, Medical Research Council (representing the Research Councils UK), Kush Naker, Policy and Advocacy Co-ordinator, Universities Allied for Essential Medicines UK, and Professor Sir Anthony Coates, Professor of Medical Microbiology, Antibiotic Discovery UK; Dr Louise Leong, Head of Research and Development, Association of the British Pharmaceutical Industry, James Anderson, Director, European Partnerships, GlaxoSmithKline, Dr David Williams, Chief Executive Officer, Discuva, and Michael McIntyre, Chair, European Herbal and Traditional Medicine Practitioners Association.
Oral Evidence
5 March 2014
Inquiry Blood, tissue and organ screening
Witnesses Dr Steven Burton, Chief Executive, ProMetic Biosciences Ltd, Dr Kelly Board, Technical Specialist, DuPont Chemicals and Fluoroproducts, Dr Alex Raeber, Head of Research and Development, Prionics AG, Nigel Talboys, Global Director of Blood Safety and EMEA Director of Public Policy and Government Affairs, Terumo BCT, and Professor John Collinge, Director, MRC Prion Unit and Professor of Neurology at the UCL Institute of Neurology.
Oral Evidence
22 January 2014
Inquiry Work of the Chief Scientific Adviser, Foreign and Commonwealth Office
Witnesses Professor Robin Grimes, Chief Scientific Adviser, Foreign and Commonwealth Office
Oral Evidence
27 January 2014
Inquiry Pre-appointment hearing - of the Arts and Humanities Research Council (AHRC)
Witnesses Professor Sir Drummond Bone, Chair-elect of the Arts and Humanities Research Council.
Oral Evidence
22 January 2014
Inquiry Government Horizon Scanning
Witnesses Rt Hon Oliver Letwin MP, Minister for Government Policy, and Sir Jeremy Heywood, Cabinet Secretary, Cabinet Office
Oral Evidence
29 January 2014
Inquiry Antimicrobial resistance (AMR)
Witnesses Phil Sketchley, Chief Executive, National Office of Animal Health, John FitzGerald, Secretary General, Responsible Use of Medicines in Agriculture Alliance, Catherine McLaughlin, Animal Health and Welfare Adviser, National Farmers’ Union, and Cóilín Nunan, Principal Scientific Adviser, Alliance to Save our Antibiotics
Oral Evidence
4 December 2013
Inquiry Government Horizon Scanning
Witnesses Sir Mark Walport, Government Chief Scientific Adviser, and Jon Day, Chair, Horizon Scanning Oversight Group, Cabinet Office
Oral Evidence
4 December 2013
Inquiry Government Office for Science Annual Review 2012-13
Witnesses Professor Sir Mark Walport, Chief Scientific Adviser to HM Government and Head of the Government Office for Science
Oral Evidence
8 January 2014
Inquiry Antimicrobial resistance (AMR)
Witnesses Professor Anthony Kessel, Director, Public Health Strategy, Public Health England, Dr Michael Moore, National Clinical Champion Antibiotic Stewardship, Royal College of General Practitioners, Professor Alison Holmes, Director of Infection Prevention and Control, National Centre for Infection Prevention and Management, Imperial College London, and Dr Susan Hopkins, Chair, Healthcare Associated Infections Working Group, Royal College of Physicians; John Hardcastle, Chief Executive Officer, Novolytics, Dr David McIntosh, Global Scientific Affairs Senior Expert, Novartis, Professor George Lewith, Professor of Health Research, University of Southampton Medical School, and Doris-Ann Williams, Chief Executive, British In Vitro Diagnostics Association
Oral Evidence
18 December 2013
Inquiry Antimicrobial resistance (AMR)
Witnesses Dr Pat Goodwin, Society of Biology, Professor Laura Piddock, British Society for Antimicrobial Chemotherapy, Professor John Threlfall, Society for Applied Microbiology, and Professor Sharon Peacock, Cambridge Infectious Diseases Initiative, University of Cambridge.
Oral Evidence
30 October 2013
Inquiry Women in STEM careers
Witnesses Dr June McCombie, former Chair of IOP Project, Juno Panel, Institute of Physics, Sarah Dickinson, Manager, Athena SWAN Charter, Equality Challenge Unit, Professor Dame Julia Higgins, Chair of Diversity Programme, Royal Society, and Dr Pia Ostergaard, Senior Fellowship Advisor, Daphne Jackson Trust; Professor Uta Frith, Emeritus Professor of Cognitive Development, University College London, representing Russell Group, Professor Jane Powell, Deputy Warden, Goldsmith's, University of London, representing 1994 Group, and Clem Herman, Senior Lecturer, Computing and Communications, Open University (at 10.15 am).
Oral Evidence
Total results 353 (page 16 of 18)